The impact of the molecular subgroups within medulloblastoma may also apply to outcomes after surgical resection, with a recent study demonstrating more aggressive surgery beyond subtotal resection does not affect progression-free survival for patients with WNT, SHH, or G3 tumors [56]. Here, SHH is linked to medulloblastoma.